Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
BONESUPPORT HOLDING AB ( (SE:BONEX) ) has shared an announcement.
BONESUPPORT HOLDING AB announced it will release its Q3 2025 interim report on October 23, followed by a conference call and online presentation hosted by the CEO and CFO. This event is significant as it provides stakeholders with insights into the company’s financial performance and strategic direction, potentially impacting its market positioning and investor relations.
The most recent analyst rating on (SE:BONEX) stock is a Hold with a SEK297.00 price target. To see the full list of analyst forecasts on BONESUPPORT HOLDING AB stock, see the SE:BONEX Stock Forecast page.
More about BONESUPPORT HOLDING AB
BONESUPPORT HOLDING AB is a prominent company in the orthobiologics industry, specializing in the development and commercialization of innovative injectable bio-ceramic bone graft substitutes. These products, based on a patented technology platform, are designed to remodel into the patient’s own bone and have the capability of eluting drugs. The company, headquartered in Lund, Sweden, is actively involved in clinical studies to demonstrate the clinical and health economic benefits of its products.
Average Trading Volume: 152,741
Technical Sentiment Signal: Sell
Current Market Cap: SEK17.39B
For a thorough assessment of BONEX stock, go to TipRanks’ Stock Analysis page.